RT Journal Article
SR Electronic
T1 Screening of SARS-CoV-2 among homeless people, asylum-seekers and other people living in precarious conditions in Marseille, France, March–April 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.05.20091934
DO 10.1101/2020.05.05.20091934
A1 Ly, Tran Duc Anh
A1 Hoang, Van Thuan
A1 Goumballa, Ndiaw
A1 Louni, Meriem
A1 Canard, Naomie
A1 Dao, Thi Loi
A1 Medkour, Hacene
A1 Borg, Audrey
A1 Bardy, Kevin
A1 Esteves-Vieira, Véra
A1 Filosa, Véronique
A1 Davoust, Bernard
A1 Mediannikov, Oleg
A1 Fournier, Pierre-Edouard
A1 Raoult, Didier
A1 Gautret, Philippe
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.05.20091934.abstract
AB Surveillance of SARS-CoV-2 infection among sheltered homeless and other vulnerable people might provide the information needed to prevent its spread within accommodation centres. In March-April, we enrolled 411 homeless individuals, 77 asylum-seekers, 58 people living in precarious conditions, and 152 employees working in these accommodation centres and collected nasal samples. SARS-CoV-2 carriage was assessed by quantitative PCR. Overall, 49 (7.0%) people were positive for SARS-CoV-2, including 37 homeless individuals (of 411, 9.0%), 12 employees (of 152, 7.9%). SARS-CoV-2 positivity correlated with symptoms, although 51% of positive patients did not report respiratory symptoms or fever. Among homeless people, being young (18-34 years) (OR: 3.83 [1.47-10.0], p=0.006) and being housed in one specific shelter (OR: 9.13 [4.09-20.37], p<0.0001) were independent factors associated with the SARS-CoV-2 positivity rates (11.4% and 20.6%, respectively). The survey reveals the role of collective housing in relation to viral transmission within centres.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the French Government under the “Investments for the Future” programme managed by the National Agency for Research (ANR), Méditerranée-Infection 10-IAHU-03, and was also supported by Région Provence-Alpes-Côte d’Azur. This work had received financial support from the Fondation Méditerranée Infection.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data availability